EurekAlert! -
1 Jun 2018 06:00
(University of Copenhagen The Faculty of Health and Medical Sciences) A large group of people with obesity have a genetic mutation that is causing their obesity. Common treatments for obesity only benefit these people to a limited extent, but now a new study conducted at the University of Copenhagen reveals that they can be treated effectively with the medicine liraglutide, which is a GLP-1 receptor agonist.
Share this Article